Hualan Biological Engineering Inc.
002007.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$24.37B
Close$
Share Statistics
| Market cap | $24.37 Billion |
|---|---|
| Enterprise Value | $23.83 Billion |
| Dividend Yield | $1.00 (7.49%) |
| Earnings per Share | $0.52 |
| Beta | 0.37 |
| Outstanding Shares | 1,825,690,986 |
Return
| Return on Equity | 7.36% |
|---|---|
| Return on Assets | 5.55% |
| Return on Invested Capital | 7.77% |
Valuation & Multiples
| P/E Ratio | 29.72 |
|---|---|
| PEG | -121.18 |
| Price to Sales | 6.68 |
| Price to Book Ratio | 2.23 |
| Enterprise Value to Revenue | 5.46 |
| Enterprise Value to EBIT | 23.88 |
| Enterprise Value to Net Income | 29 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 28, 2026
EPS Estimate
$0.11
Average shareholder expectationRevenue Estimate
$852.78 M
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
$0.13
Average shareholder expectationRevenue Estimate
$1.34 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Hualan Biological Engineering Inc.
4,117 employees
CEO: Bei Fan Hualan Biological Engineering Inc. operates as a biopharmaceutical company, specializing in the research, development, production, and commercialization of a diverse portfolio of medical products within the People's Republic of China. It...